Key result
Excluding macrotroponin lowers Siemens hs-cTnI 99th percentiles up to ~81% without affecting hs-cTnT.
Why the study?
Does the exclusion of macrotroponin-positive samples lower the 99th percentile threshold in high-sensitivity cardiac troponin assays among healthy individuals?
Cross-Sectional (n=1,058)
Does the exclusion of macrotroponin-positive samples lower the 99th percentile threshold in high-sensitivity cardiac troponin assays among healthy individuals?
Macrotroponin significantly inflates the 99th percentile threshold for the Siemens Atellica hs-cTnI assay, but not the Roche hs-cTnT assay, highlighting the need to account for this interference when establishing reference limits.
Answers are grounded in this paper and cite their sources.
May alter hs-cTnI interpretation in macrotroponin-positive patients; leaves open assay-specific reference limit adjustments.
BACKGROUND: Cardiac troponin (cTn) levels exceeding the 99th percentile upper reference limit and a rise/fall pattern are key for diagnosing myocardial injury and infarction. Macrotroponins, formed by patient anti-cTn antibodies targeting cTn, can cause persistently elevated cTn levels without ongoing myocardial injury. The frequency and impact of macrotroponin interference on cTn 99th percentiles are unclear. This study compares sex-specific 99th percentiles for 2 cTn assays, before and after excluding macrotroponin-positive samples, focusing on the top 10% of cTn levels. METHODS: We examined 1058 plasma samples from healthy individuals previously used for Danish cTn 99th percentiles. Following International Federation of Clinical Chemistry and Laboratory Medicine educational recommendations, macrotroponin presence was assessed in the top 10% cTn samples using immunoglobulin G (IgG) depletion screening and a reference sucrose gradient, confirming macrotroponin when both methods concurred. Due to analytical dilution constraints, [the highest] 88 of 135 Siemens Atellica high-sensitivity cTnI (hs-cTnI) samples were analyzed with both methods. All 106 Roche hs-cTnT samples were negative using IgG depletion, and sucrose analysis was limited to the highest 70 samples. RESULTS: Macrotroponin was found in 76% (67/88) of Siemens samples but in none of the Roche samples (0/70). Excluding macrotroponin-affected samples lowered the Siemens 99th percentiles from 117 ng/L to 22 ng/L in men and from 37 ng/L to 9 ng/L in women. The 99th/50th percentile ratio for Siemens decreased from 12- to 29-fold to 3- to 7-fold, approaching the Roche ratios. CONCLUSIONS: Macrotroponin significantly influenced the Siemens Atellica hs-cTnI 99th percentiles, suggesting important clinical implications that warrant further prospective studies. The 99th/50th percentile ratio may help evaluate macrotroponin interference in troponin assays.
No takes yet. Share an insight, caveat, or question.
Strandkjær et al. (2025) conducted a cross-sectional in Healthy individuals (n=1,058). Macrotroponin interference vs. No macrotroponin interference was evaluated on Sex-specific 99th percentiles for 2 cTn assays before and after excluding macrotroponin-positive samples. Excluding macrotroponin-affected samples lowered the Siemens Atellica hs-cTnI 99th percentiles from 117 to 22 ng/L in men and from 37 to 9 ng/L in women, while Roche hs-cTnT was unaffected.
Synapse has enriched 10 related papers. Consider them for comparative context: